Trials / Conditions / Paroxysmal Hemoglobinuria
Paroxysmal Hemoglobinuria
3 registered clinical trials studyying Paroxysmal Hemoglobinuria — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) NCT04901936 | Apellis Pharmaceuticals, Inc. | Phase 2 |
| Completed | Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH NCT04463056 | AO GENERIUM | Phase 3 |
| Completed | Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria NCT00039923 | National Heart, Lung, and Blood Institute (NHLBI) | — |